Activation of the stress-activated protein kinase JNK in response to herpes simplex virus-1 infection coordinates transition of BRD4 from chromosome association to transcription elongation
- J Biol Chem. 2025 Sep;301(9):110590. doi: 10.1016/j.jbc.2025.110590.
- 1. State Key Laboratory of Pharmaceutical Biotechnology and Medical School, Nanjing University, Nanjing, Jiangsu, China; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, Jiangsu, China.
- 2. School of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
- 3. Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, Jiangsu, China.
- 4. State Key Laboratory of Pharmaceutical Biotechnology and Medical School, Nanjing University, Nanjing, Jiangsu, China; College of Life Sciences, Nanjing University, Nanjing, China.
- 5. School of Medical Informatics, Xihua University, Chengdu, Sichuan, China. Electronic address: [email protected].
- 6. State Key Laboratory of Pharmaceutical Biotechnology and Medical School, Nanjing University, Nanjing, Jiangsu, China; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, Jiangsu, China; Institute of Medical Virology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China. Electronic address: [email protected].
The c-Jun N-terminal kinase (JNK) signaling pathway is required for herpes simplex virus 1 lytic Infection and reactivation from latency. JNK signaling regulates cellular processes in response to stress through transcriptional regulation. However, the mechanisms by which JNK regulates HSV-1 Infection are less defined. We show here that HSV-1 Infection triggers BRD4 transition from chromosome association to transcriptional regulation for viral Infection. Specifically, HSV-1 Infection induces JNK activation which mediates redistribution of BRD4, an epigenetic reader protein, from chromatin-targeting to association with proteins of transcriptional regulation. BRD4 transitions to viral Infection regulation by complexing with P-TEFb, a positive transcription elongation factor, and association with viral DNA. Genetic ablation or perturbation of JNK with chemical inhibitors or siRNA leads to impediment of BRD4 release and inhibition of HSV-1 Infection. Both chemotherapeutic agents and irradiation are known to promote JNK activation and HSV reactivation. We show further that JNK agonist or chemotherapeutic agents known to activate JNK can enhance HSV-1 Infection. Our study reveals a novel mechanism by which JNK regulates HSV-1 Infection through stress-induced BRD4 function transition from host chromosome association to viral gene expression. The work links recurrent HSV Infection by chemotherapeutic agents to JNK activation.